BI
Bioasis Technologies Inc.
BIOAF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $11.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.30x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 70.18%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak FCF margin 9,636.86%
Op. margin 12,784.50%
Gross margin 3,150.25%
Quality
0 /100
Poor ROA 130.64%
Asset turnover 0.02x
ROIC 621.16%
Debt
54 /100
Moderate Int. coverage -5.50x
Net debt/EBITDA -0.05x
Current ratio 0.70x
Stability
4 /100
Unstable Profitable years 0
EPS volatility 324.98%
Beta 1.74x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BIOAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Deborah Ann Rathjen
Employees
4
Headquarters
New Haven
Nadcházející události
02 LIS
Earnings
Upcoming earnings report